Am happy too to see that they keep overperforming a booming market by a significant margin.I still find the trading volume pretty low and can't understand why.Maybe we should suggest Fat Prophets to cover this stock ...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come